174 related articles for article (PubMed ID: 10598188)
1. Vascular endothelial growth factor-C gene expression in papillary and follicular thyroid carcinomas.
Fellmer PT; Sato K; Tanaka R; Okamoto T; Kato Y; Kobayashi M; Shibuya M; Obara T
Surgery; 1999 Dec; 126(6):1056-61; discussion 1061-2. PubMed ID: 10598188
[TBL] [Abstract][Full Text] [Related]
2. Co-regulatory potential of vascular endothelial growth factor-A and vascular endothelial growth factor-C in thyroid carcinoma.
Salajegheh A; Pakneshan S; Rahman A; Dolan-Evans E; Zhang S; Kwong E; Gopalan V; Lo CY; Smith RA; Lam AK
Hum Pathol; 2013 Oct; 44(10):2204-12. PubMed ID: 23845470
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor expression is higher in differentiated thyroid cancer than in normal or benign thyroid.
Soh EY; Duh QY; Sobhi SA; Young DM; Epstein HD; Wong MG; Garcia YK; Min YD; Grossman RF; Siperstein AE; Clark OH
J Clin Endocrinol Metab; 1997 Nov; 82(11):3741-7. PubMed ID: 9360534
[TBL] [Abstract][Full Text] [Related]
4. [Pathologic study of expression and significance of matrix metalloproteinases-9, tissue inhibitor of metalloproteinase-1, vascular endothelial growth factor and transforming growth factor beta-1 in papillary carcinoma and follicular carcinoma of thyroid].
Wang T; Jiang CX; Li Y; Liu X
Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):824-8. PubMed ID: 20193458
[TBL] [Abstract][Full Text] [Related]
5. VEGF-D expression and lymph vessels play an important role for lymph node metastasis in papillary thyroid carcinoma.
Yasuoka H; Nakamura Y; Zuo H; Tang W; Takamura Y; Miyauchi A; Nakamura M; Mori I; Kakudo K
Mod Pathol; 2005 Aug; 18(8):1127-33. PubMed ID: 15803188
[TBL] [Abstract][Full Text] [Related]
6. Concomitant high expression of survivin and vascular endothelial growth factor-C is strongly associated with metastatic status of lymph nodes in papillary thyroid carcinoma.
Selemetjev S; Savin S; Paunovic I; Tatic S; Cvejic D
J Cancer Res Ther; 2018; 14(Supplement):S114-S119. PubMed ID: 29578160
[TBL] [Abstract][Full Text] [Related]
7. Expression of the cell death-inducing gene bax in carcinomas developed from the follicular cells of the thyroid gland.
Branet F; Brousset P; Krajewski S; Schlaifer D; Selves J; Reed JC; Caron P
J Clin Endocrinol Metab; 1996 Jul; 81(7):2726-30. PubMed ID: 8675602
[TBL] [Abstract][Full Text] [Related]
8. [Expression and significance of VEGF, VEGF-C, and VEGF-D in papillary thyroid carcinoma].
Jiang HG; Gao M; Tang WP; Li FH; Cai QZ
Ai Zheng; 2005 Sep; 24(9):1136-9. PubMed ID: 16159441
[TBL] [Abstract][Full Text] [Related]
9. Expression of vascular endothelial growth factor-C in benign and malignant thyroid tumors.
Hung CJ; Ginzinger DG; Zarnegar R; Kanauchi H; Wong MG; Kebebew E; Clark OH; Duh QY
J Clin Endocrinol Metab; 2003 Aug; 88(8):3694-9. PubMed ID: 12915657
[TBL] [Abstract][Full Text] [Related]
10. Serum vascular endothelial growth factor levels are elevated in metastatic differentiated thyroid cancer but not increased by short-term TSH stimulation.
Tuttle RM; Fleisher M; Francis GL; Robbins RJ
J Clin Endocrinol Metab; 2002 Apr; 87(4):1737-42. PubMed ID: 11932308
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases.
Yu XM; Lo CY; Chan WF; Lam KY; Leung P; Luk JM
Clin Cancer Res; 2005 Nov; 11(22):8063-9. PubMed ID: 16299237
[TBL] [Abstract][Full Text] [Related]
12. Expression of vascular endothelial growth factor (VEGF) in human thyroid neoplasms.
Katoh R; Miyagi E; Kawaoi A; Hemmi A; Komiyama A; Oyama T; Shibuya M
Hum Pathol; 1999 Aug; 30(8):891-7. PubMed ID: 10452500
[TBL] [Abstract][Full Text] [Related]
13. Follicular, papillary, and "hybrid" carcinomas of the thyroid.
Castro P; Fonseca E; Magalhães J; Sobrinho-Simões M
Endocr Pathol; 2002; 13(4):313-20. PubMed ID: 12665649
[TBL] [Abstract][Full Text] [Related]
14. MUC1 mucin gene, transcripts, and protein in adenomas and papillary carcinomas of the thyroid.
Bièche I; Ruffet E; Zweibaum A; Vildé F; Lidereau R; Franc B
Thyroid; 1997 Oct; 7(5):725-31. PubMed ID: 9349575
[TBL] [Abstract][Full Text] [Related]
15. Synchronous and Metastatic Papillary and Follicular Thyroid Carcinomas with Unique Molecular Signatures.
Cracolici V; Mujacic I; Kadri S; Alikhan M; Niu N; Segal JP; Rosen LE; Sarne DH; Morgan A; Desouky S; Cipriani NA
Endocr Pathol; 2018 Mar; 29(1):9-14. PubMed ID: 28710706
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor-C expression correlates with lymph node localization of human melanoma metastases.
Schietroma C; Cianfarani F; Lacal PM; Odorisio T; Orecchia A; Kanitakis J; D'Atri S; Failla CM; Zambruno G
Cancer; 2003 Aug; 98(4):789-97. PubMed ID: 12910524
[TBL] [Abstract][Full Text] [Related]
17. Contribution of p53 gene alterations to development of metastatic forms of follicular thyroid carcinoma.
Sápi Z; Lukács G; Sztán M; Papp J; Oláh E
Diagn Mol Pathol; 1995 Dec; 4(4):256-60. PubMed ID: 8634781
[TBL] [Abstract][Full Text] [Related]
18. Mixed medullary-follicular carcinoma of the thyroid. A morphological, immunohistochemical and in situ hybridization analysis of 11 cases.
Papotti M; Negro F; Carney JA; Bussolati G; Lloyd RV
Virchows Arch; 1997 May; 430(5):397-405. PubMed ID: 9174630
[TBL] [Abstract][Full Text] [Related]
19. Intensity of vascular endothelial growth factor expression is associated with increased risk of recurrence and decreased disease-free survival in papillary thyroid cancer.
Lennard CM; Patel A; Wilson J; Reinhardt B; Tuman C; Fenton C; Blair E; Francis GL; Tuttle RM
Surgery; 2001 May; 129(5):552-8. PubMed ID: 11331447
[TBL] [Abstract][Full Text] [Related]
20. Expression of vascular endothelial growth factor (VEGF) in human thyroid tumors.
Lewy-Trenda I; Wierzchniewska-Ławska A
Pol J Pathol; 2002; 53(3):129-32. PubMed ID: 12476614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
